dr. vogelzang describes cabozantinib's side effects
Published 13 years ago • 1.4K plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:45
dr. vogelzang discusses cabozantinib's dose size
-
1:11
dr. vogelzang on xl184's effect on bone metastases
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:35
dr. vogelzang discusses cabozantinib trial design
-
0:56
dr. vogelzang on cabozantinib clinical trial results
-
1:34
dr. vogelzang discusses the cabozantinib trial design
-
2:22
nicholas vogelzang, md, discusses re-emergence of dose reduced cabozantinib alezotuzumab in apc
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
1:27
dr. ezra cohen on the efficacy and pharmacokinetics of cabozantinib
-
1:14
what kind of developments in kidney cancer care and treatment can we expect in the next few years?
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:25
managing side effects of cabozantinib treatment for metastatic renal cell carcinoma
-
1:19
dr. nicholas vogelzang on first-line axitinib versus sorafenib in mrcc
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer
-
1:53
dr. nicholas vogelzang discusses sequencing abiraterone and enzalutamide
-
10:25
for hcps: learn about the cabometyx® (cabozantinib) mechanism of action
-
6:00
clinical rationale for cabozantinib in hcc
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...